PHARMACYCLICS INC Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 43 rows in 2011. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2011-12-30: Reporting owner Hemmi Gregory; Form 4; Security Employee Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2011-12-30: Reporting owner Hemmi Gregory; Form 4; Security Employee Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2011-12-30: Reporting owner Hemmi Gregory; Form 4; Security Employee Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2011-12-15: Reporting owner van den Broek Richard; Form 4; Security Non-qualified Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2011-12-30 | Hemmi Gregory Officer (VP Chemical Operations) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −6,563 8,437 owned after | $7.39 exercise price | 2012-01-03 | |
| 2011-12-30 | Hemmi Gregory Officer (VP Chemical Operations) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −8,437 0 owned after | $7.39 exercise price | 2012-01-03 | |
| 2011-12-30 | Hemmi Gregory Officer (VP Chemical Operations) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,125 1,875 owned after | $4.25 exercise price | 2012-01-03 | |
| 2011-12-15 | van den Broek Richard Director | 4 | Non-qualified Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,500 7,500 owned after | $14.26 exercise price | 2011-12-19 | |
| 2011-12-15 | Smith David Duane Director | 4 | Non-qualified Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,500 7,500 owned after | $14.26 exercise price | 2011-12-19 | |
| 2011-12-15 | Mehta Minesh Director | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,500 7,500 owned after | $14.26 exercise price | 2011-12-19 | |
| 2011-12-15 | Hardiman Roy C. Director | 4 | Non-qualified Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,500 7,500 owned after | $14.26 exercise price | 2011-12-19 | |
| 2011-12-15 | Booth Robert F. Director | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,500 7,500 owned after | $14.26 exercise price | 2011-12-19 | |
| 2011-12-15 | HALVORSON ERIC H Director | 4 | Non-qualified Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $14.26 exercise price | 2011-12-19 | |
| 2011-12-02 | Loury David J Officer (Chief Scientific Officer) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,500 7,500 owned after | $15.63 exercise price | 2011-12-06 | |
| 2011-12-02 | Hemmi Gregory Officer (VP Chemical Operations) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $15.63 exercise price | 2011-12-06 | |
| 2011-12-02 | Hedrick Eric Officer (Vice President) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $15.63 exercise price | 2011-12-06 | |
| 2011-12-02 | Erdtmann Rainer M Officer (VP of Finance) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $15.63 exercise price | 2011-12-06 | |
| 2011-12-02 | Buggy Joseph J Officer (VP, Research) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $15.63 exercise price | 2011-12-06 | |
| 2011-12-02 | Asbury Mark Officer (VP and General Counsel) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,000 5,000 owned after | $15.63 exercise price | 2011-12-06 | |
| 2011-12-01 | Zanganeh Maky Officer (Chief Business Officer) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −100,000 100,000 owned after | $14.92 exercise price | 2011-12-05 | |
| 2011-12-01 | Kunkel Lori Anne Officer (Chief Medical Officer) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +300,000 300,000 owned after | $14.92 exercise price | 2011-12-05 | |
| 2011-10-03 | Smith David Duane Director | 4 | Non-qualified Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +2,917 2,917 owned after | $11.31 exercise price | 2011-10-05 | |
| 2011-10-03 | Fyfe Gwen A. Director | 4 | Non-qualified Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +2,652 2,652 owned after | $11.31 exercise price | 2011-10-05 | |
| 2011-10-03 | Mehta Minesh Director | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,126 1,126 owned after | $11.31 exercise price | 2011-10-05 | |
| 2011-10-03 | van den Broek Richard Director | 4 | Non-qualified Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +2,784 2,784 owned after | $11.31 exercise price | 2011-10-05 | |
| 2011-10-03 | Hardiman Roy C. Director | 4 | Non-qualified Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,989 1,989 owned after | $11.31 exercise price | 2011-10-05 | |
| 2011-10-03 | Booth Robert F. Director | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,989 1,989 owned after | $11.31 exercise price | 2011-10-05 | |
| 2011-07-13 | Hemmi Gregory Officer (VP Chemical Operations) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −6,000 44,000 owned after | $0.75 exercise price | 2011-07-15 | |
| 2011-07-01 | Mehta Minesh Director | 4/A | Non-Qualified Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,204 1,204 owned after | $10.58 exercise price | 2011-09-28 | |
| 2011-07-01 | Booth Robert F. Director | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +2,126 2,126 owned after | $10.58 exercise price | 2011-07-06 | |
| 2011-07-01 | Fyfe Gwen A. Director | 4 | Non-qualified Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +2,126 2,126 owned after | $10.58 exercise price | 2011-07-06 | |
| 2011-07-01 | Hardiman Roy C. Director | 4 | Non-qualified Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +2,126 2,126 owned after | $10.58 exercise price | 2011-07-06 | |
| 2011-07-01 | Mehta Minesh Director | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,133 1,133 owned after | $10.58 exercise price | 2011-07-06 | |
| 2011-07-01 | Smith David Duane Director | 4 | Non-qualified Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +2,409 2,409 owned after | $10.58 exercise price | 2011-07-06 | |
| 2011-07-01 | van den Broek Richard Director | 4 | Non-qualified Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +2,976 2,976 owned after | $10.58 exercise price | 2011-07-06 | |
| 2011-07-01 | Asbury Mark Officer (VP and General Counsel) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +250,000 250,000 owned after | $10.58 exercise price | 2011-07-06 | |
| 2011-06-14 | Hedrick Eric Officer (Vice President, Interim CMO) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +30,000 30,000 owned after | $8.88 exercise price | 2011-06-16 | |
| 2011-04-28 | Zanganeh Maky Officer (Chief of Staff & VP Bus. Dev.) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −20,000 130,000 owned after | $0.75 exercise price | 2011-05-02 | |
| 2011-04-01 | Fyfe Gwen A. Director | 4 | Non-qualified Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +3,743 3,743 owned after | $6.01 exercise price | 2011-04-05 | |
| 2011-04-01 | Hardiman Roy C. Director | 4 | Non-qualified Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +3,743 3,743 owned after | $6.01 exercise price | 2011-04-05 | |
| 2011-04-01 | Booth Robert F. Director | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +3,743 3,743 owned after | $6.01 exercise price | 2011-04-05 | |
| 2011-04-01 | Mehta Minesh Director | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +124 124 owned after | $6.01 exercise price | 2011-04-05 | |
| 2011-04-01 | Smith David Duane Director | 4 | Non-qualified Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +4,242 4,242 owned after | $6.01 exercise price | 2011-04-05 | |
| 2011-04-01 | van den Broek Richard Director | 4 | Non-qualified Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,240 5,240 owned after | $6.01 exercise price | 2011-04-05 | |
| 2011-01-03 | van den Broek Richard Director | 4 | Non-qualified Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +4,140 4,140 owned after | $6.52 exercise price | 2011-01-05 | |
| 2011-01-03 | Smith David Duane Director | 4 | Non-qualified Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +3,680 3,680 owned after | $6.52 exercise price | 2011-01-05 | |
| 2011-01-03 | Mehta Minesh Director | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +2,185 2,185 owned after | $6.52 exercise price | 2011-01-05 |